Tenet Healthcare downgraded by Wells Fargo with a new price target
$THC
Hospital/Nursing Management
Health Care
Wells Fargo downgraded Tenet Healthcare from Overweight to Equal Weight and set a new price target of $150.00 from $205.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/25/2024 | $205.00 → $150.00 | Overweight → Equal Weight | Wells Fargo |
| 11/22/2024 | $195.00 | Strong Buy → Outperform | Raymond James |
| 10/11/2024 | $200.00 | Overweight | KeyBanc Capital Markets |
| 5/30/2024 | $153.00 | Outperform | Robert W. Baird |
| 3/27/2024 | $122.00 | Peer Perform → Outperform | Wolfe Research |
| 3/6/2024 | $113.00 | Overweight | Barclays |
| 4/21/2023 | $73.00 | Overweight | Cantor Fitzgerald |
| 4/19/2023 | $72.00 | Overweight | JP Morgan |
SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)
SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)
SC 13G - TENET HEALTHCARE CORP (0000070318) (Subject)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
MOUNTAIN VIEW, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Commure, a leader in healthcare technology innovation, announced today that Tenet Healthcare Corporation (NYSE:THC), one of the nation's largest healthcare providers, has selected Commure Scribe, an ambient AI platform, to be launched across its employed physician network, Tenet Physician Resources. This relationship solidifies Commure as the most comprehensive platform solution provider for AI within health systems. Its reach includes tens of thousands of physicians across sixty of the largest IDNs (Integrated Delivery Networks) in the country. Commure's ambient AI platform spans the entire patient journey and clinician workflow,
Net income available to common shareholders in third quarter 2024 was $472 million, or $4.89 per diluted share, including an after-tax gain of $209 million, or $2.16 per diluted share, primarily associated with previously announced hospital divestitures Adjusted diluted earnings per share1 was $2.93 in third quarter 2024 Consolidated Adjusted EBITDA1 in third quarter 2024 of $978 million increased 14.5% over third quarter 2023 Third quarter 2024 Ambulatory Care Adjusted EBITDA of $439 million increased 18.6% over third quarter 2023 FY 2024 Adjusted EBITDA Outlook now expected to be in the range of $3.9 billion to $4.0 billion, a $50 million increase Tenet Healthcare Corporati
Tenet Healthcare Corporation (NYSE:THC) is scheduled to present at the UBS Global Healthcare Conference on Tuesday, November 12, 2024, beginning at 12:30 p.m. Eastern time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We al
Tenet Healthcare Corporation (NYSE:THC) will release its third quarter 2024 results before the market opens on Tuesday, October 29, 2024, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We a
Tenet Healthcare Corporation (NYSE:THC) will release its second quarter 2024 results on Wednesday, July 24, 2024, no later than 6:00 a.m. Central Time (CT), to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and su
Tenet Healthcare Corporation (NYSE:THC) will release its first quarter 2024 results on Tuesday, April 30, 2024, no later than 6:00 a.m. Central Time (CT), to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in more
Tenet Healthcare Corporation (NYSE:THC) today announced the appointment of Vineeta Agarwala, M.D., PhD, to its Board of Directors, effective immediately. Dr. Agarwala will serve as a member of the Quality, Compliance, and Ethics Committee, as well as the Human Resources Committee, increasing the size of the Board to 13 directors. "We are pleased to welcome Dr. Vineeta Agarwala to the Tenet Board," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "Vineeta is a leader in healthcare in her own right. Her expertise in innovative technologies, including applications of artificial intelligence will enhance our governance in a rapidly evolving healthcare marketplace." Dr
Tenet Healthcare Corporation (NYSE:THC) today announced the appointment of Senator Roy Blunt to the Tenet Board of Directors, effective immediately. Senator Blunt will serve as a member of the Audit Committee, Nominating and Corporate Governance Committee, and Environmental, Social, and Governance Committee. This appointment expands the Board to 12 directors, 11 of whom are independent members. "We are pleased to welcome Senator Roy Blunt as a new board member," said Saum Sutaria, M.D., Chief Executive Officer of Tenet. "With more than 25 years of legislative experience, Roy's expertise in public policy and addressing cross-cutting issues will be invaluable to helping Tenet make a lasting
Tenet Healthcare Corporation (NYSE:THC) today announced that its Board of Directors has elected Chief Executive Officer, Saum Sutaria, M.D., to assume the additional position of Chairman, effective immediately. Sutaria succeeds Senator J. Robert Kerrey, who will transition to Lead Director of the Board, a role he previously held from 2017- 2022. Sutaria has served as Tenet Healthcare's CEO since September 2021 and a member of the Board of Directors since 2020. Previously, he served as the Company's Chief Operating Officer. "The appointment of Saum to Chairman is a testament to his steadfast leadership and commitment to Tenet Healthcare," said Senator J. Robert Kerrey, Lead Director. "Th
10-Q - TENET HEALTHCARE CORP (0000070318) (Filer)
8-K - TENET HEALTHCARE CORP (0000070318) (Filer)
8-K - TENET HEALTHCARE CORP (0000070318) (Filer)
Wells Fargo downgraded Tenet Healthcare from Overweight to Equal Weight and set a new price target of $150.00 from $205.00 previously
Raymond James downgraded Tenet Healthcare from Strong Buy to Outperform and set a new price target of $195.00
KeyBanc Capital Markets initiated coverage of Tenet Healthcare with a rating of Overweight and set a new price target of $200.00
Ratings for Tenet Healthcare (NYSE:THC) were provided by 17 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 7 9 1 0 0 Last 30D 1 1 0 0 0 1M Ago 2 4 0 0 0 2M Ago 1 2 0 0 0 3M Ago 3 2 1 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $141.06, along with a high estimate of $170.
Truist Securities analyst David Macdonald reiterates Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $155 to $170.
Cantor Fitzgerald analyst Sarah James maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $112 to $168.